Naltrexone Contraindications and Alternatives for Pain Management

Mechanism and Contraindication

Naltrexone functions as a competitive antagonist at mu, kappa, and delta opioid receptors, completely blocking the analgesic effects of opioid medications, as stated by the American College of Clinical Pharmacology 1
The FDA explicitly contraindicates naltrexone in patients receiving opioid analgesics, as it prevents opioids from providing pain relief, according to the Mayo Clinic guidelines 2, 3

Extended-release naltrexone (Vivitrol) has a prolonged duration of action, requiring discontinuation 24-30 days before elective surgery if opioid analgesia will be needed, as recommended by the American Society of Anesthesiologists 2, 3
Oral naltrexone must be held 2-3 days prior to procedures requiring opioid pain management due to its active metabolite (6-β-naltrexol) with a 13-hour half-life that accumulates during therapy, according to the American College of Clinical Pharmacology 2, 3

The FDA recommends non-opioid approaches, including general anesthesia for surgical procedures, as stated by the Mayo Clinic Proceedings 3

Patients who discontinue naltrexone have markedly increased risk of opioid overdose and death due to loss of opioid tolerance during treatment, as warned by the American College of Clinical Pharmacology 4